These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4313048)

  • 21. Effect on seroprevalence of anti-poliovirus antibodies and on vaccination coverage of the implementation of a DTwP-IPV-Hib vaccination programme in a South American city.
    Nates SV; Frias M; Belfiore S; Isa MB; Martinez LC; Chuit R; Armoni J; Luxemburger C
    Epidemiol Infect; 2011 Jun; 139(6):826-35. PubMed ID: 20587121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Distribution and characteristics of poliovirus strains circulating in Poland in 1968-1972. II. Genetic characteristics of strains isolated during the 1968 poliomyelitis epidemic, from sporadic cases and from sewage].
    Kańtoch M; Dobrowolska H; Jarzabek Z; Jankowski M
    Med Dosw Mikrobiol; 1975; 27(4):365-71. PubMed ID: 175225
    [No Abstract]   [Full Text] [Related]  

  • 23. Poliomyelitis vaccination of infants: preimmunization status and seroconversion.
    Choudhury DS; Nossik NN; Bindu ; Vijayan P; Raghavan NG; Paul SS
    Bull World Health Organ; 1973; 48(2):195-8. PubMed ID: 4352611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristics of the genome of poliovirus type 3 isolated from patients with poliomyelitis in Moldavia].
    Lipskaia GIu; Seĭbil' VB; Malyshkina LP; Gidirim VN; Drozdov SG
    Mol Gen Mikrobiol Virusol; 1985 Sep; (9):27-32. PubMed ID: 3025721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virologic surveillance and progress toward poliomyelitis eradication--Eastern Mediterranean Region, 1995-September 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Nov; 47(46):1001-5. PubMed ID: 9843327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Several virologic and biochemical aspects of vaccination with antipoliomyelitis vaccine. Fate of the parent virus].
    Kiselev FL; Sadogurskaia EM; Gorshunova LP
    Vopr Virusol; 1977; (2):184-9. PubMed ID: 197713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vaccination against poliomyelitis].
    Cellesi C; Rossolini A
    Pediatr Med Chir; 1984; 6(1):13-5. PubMed ID: 6099548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
    Stenvik M; Hovi L; Siimes MA; Roivainen M; Hovi T
    Pediatr Infect Dis J; 1987 Dec; 6(12):1106-10. PubMed ID: 2829105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-poliomyelitis campaign in Taiwan.
    Hsu ST; Lin SY
    Southeast Asian J Trop Med Public Health; 1971 Jun; 2(2):140-6. PubMed ID: 4332824
    [No Abstract]   [Full Text] [Related]  

  • 30. Stopping poliovirus vaccination after eradication: issues and challenges.
    Wood DJ; Sutter RW; Dowdle WR
    Bull World Health Organ; 2000; 78(3):347-57. PubMed ID: 10812731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [On an epidemic outbreak of poliomyelitis, type 3, in the Voivode County of Poznań in 1968].
    Walter T
    Zentralbl Bakteriol Orig; 1969; 211(2):162-6. PubMed ID: 4318358
    [No Abstract]   [Full Text] [Related]  

  • 32. Study of the effect of vaccination with live poliomyelitis vaccine on the circulation of enteroviruses in the population.
    Tarabcák M; Kratochvil I; Milosovicová A
    J Hyg Epidemiol Microbiol Immunol; 1971; 15(3):258-66. PubMed ID: 4329049
    [No Abstract]   [Full Text] [Related]  

  • 33. Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission.
    Aylward RB; Cochi SL
    Bull World Health Organ; 2004 Jan; 82(1):40-6. PubMed ID: 15106299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z
    Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genetic markers of local poliovirus strains isolated during 1966-1969].
    Nikolova M; Tsilka E; Rangelova S; Giurova S
    Izv Mikrobiol Inst (Sofiia); 1971; 22():113-8. PubMed ID: 4340615
    [No Abstract]   [Full Text] [Related]  

  • 36. Evolution of poliovirus since introduction of attenuated vaccine.
    Cossart YE
    Br Med J; 1977 Jun; 1(6077):1621-3. PubMed ID: 194650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Several virologic and biochemical aspects of vaccination with antipoliomyelitis vaccine. Characteristics of intracellular virus-specific structures].
    Sadogurskaia EM; Gorshunova LP; Kiselev FL
    Vopr Virusol; 1977; (2):189-92. PubMed ID: 197714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of a mass poliomyelitis vaccination program on the occurrence of enteroviruses in seawater.
    Lucena F; Schwartzbrod L; Bosch A
    Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1986 Dec; 183(1):67-9. PubMed ID: 3033952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of inactivated poliomyelitis vaccine for primary vaccination].
    Li CG; Ying ZF; Wang JF; Fang HH; Li YP; Li RC; Bonnet MC; Zhang YP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):501-3. PubMed ID: 19950717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of an ELISA kit made in our laboratory for intratypic discrimination of poliovirus type 1 strains isolated from acute flask paralysis].
    Ozkaya E; Arita M
    Mikrobiyol Bul; 2002 Jan; 36(1):71-7. PubMed ID: 12476769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.